Lisdexamfetamine Dimesylate 31722-0322-01
- Manufacturer
- Camber Pharmaceuticals, Inc.
- Dosage Form
- Tablet, Chewable
- Route
- Oral
- Product Type
- Human Prescription Drug
- DEA Schedule
- Schedule CII
- Marketing Start
- August 25, 2023
- Listing Expires
- December 31, 2026
- Application
- ANDA217068
Active Ingredients
| Ingredient | Strength |
|---|---|
| Lisdexamfetamine Dimesylate | 20 mg/1 |
Drug Class
Central Nervous System Stimulant [EPC]Central Nervous System Stimulation [PE]
Selected Package
31722-0322-01Selected100 TABLET, CHEWABLE in 1 BOTTLE (31722-322-01)